biostudies-literatureUnknown104(7)Cheung LCHaematologicae300-e303https://www.ebi.ac.uk/biostudies/studies/S-EPMC6601077biostudies-literatureRomidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia.PMC6601077Ford JLock RBOommen JCheung LCKees URHughes AMFerrari EKotecha RSCruickshank MNSingh SMalinge SChua GAfalseRomidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia.2019-01-01T00:00:00Z2019 Jul2025-04-22T20:25:06.351Z2025-04-06T03:06:42.847ZS-EPMC66010773067933010.3324/haematol.2018.192906